title: High frequency of the X-chromosome inactivation in young female patients with high-grade glioma.
abstract: BACKGROUND
  Gliomas are common tumors and high-grade ones account for 62% of primary malignant brain tumors. Though current evidence have suggested that inherited risks play a role in glioma susceptibility, it was conveyed that glioma was such a complex disease, and the direct genetic contribution to glioma risk factors and its relation to other factors should be discussed more deeply. X-chromosome inactivation (XCI) is the mechanism by which gene dosage equivalence is achieved between female mammals with two X chromosomes and male mammals with a single X chromosome. As skewed XCI has been linked to development of some solid tumors, including ovarian, breast, and pulmonary and esophageal carcinomas, it is challenging to elucidate the relation of skewed XCI to high-grade gliomas development.
  
  
  OBJECTIVE
  The present study aimed to determine the general concordance between XCI pattern in blood cells and brain tissues, and SXCI frequencies in female patients with high-grade glioma compared to healthy controls.
  
  
  METHODS
  1,103 Chinese females without a detectable tumor and 173 female high-grade glioma patients, were detected in the study. Normal brain tissues surrounding the lesions in gliomas were obtained from 49 patients among the 173 ones, with the microdissection using a laser microdissection microscope Genomic DNA was extracted from the peripheral blood cells and the normal brain tissues from the subjects. Exon 1 of androgen receptor (AR) gene was amplified, and its products of different alleles were resolved on denaturing polyacrylamide gels and visualized after silver staining. The corrected ratios (CR) of the products before and after HpaII digestion were calculated.
  
  
  RESULTS
  Occurrence of SXCI was detected in both the patients and controls at similar frequencies. However, the phenomenon, as defined as CR ≥ 3, was more frequent in the patients aging ≤ 40 (23.6%) compared to the corresponding reference group (5.1%, P <0.0001). When CR ≥ 10 was adopted, the frequencies were 5.5% and 1.6%, respectively. Their difference did not attain statistical significance (P=0.10). When detected, both blood cells and brain tissue were compared after determination of a high concordance of XCI between blood cells and brain tissue collected from the same individuals (n=48, r =0.57, P <0.01).
  
  
  CONCLUSIONS
  The data from the current study demonstrated that SXCI may be a predisposing factor for development of high-grade glioma in young female patients and further study will verify its suitability as a biomarker to assess susceptibility of young female patients to high-grade glioma.
  The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1935066233982578.
authors.affiliation: Department of Neurosurgery, Tangdu hospital, the Fourth Military Medical University, 710038 Xi'an, China. che
authors.forename: Gang
authors.initials: G
authors.lastname: Li
authors.forename: Zhiguo
authors.initials: Z
authors.lastname: Zhang
authors.forename: Tianbo
authors.initials: T
authors.lastname: Jin
authors.forename: Hongjuan
authors.initials: H
authors.lastname: Liang
authors.forename: Yanyang
authors.initials: Y
authors.lastname: Tu
authors.forename: Li
authors.initials: L
authors.lastname: Gong
authors.forename: Zhongping
authors.initials: Z
authors.lastname: Chen
authors.forename: Guodong
authors.initials: G
authors.lastname: Gao
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000235:genetics*; D001932:Brain Neoplasms / Q000097:blood / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D016022:Case-Control Studies; D002681:China; D005091:Exons; D005260:Female; D020022:Genetic Predisposition to Disease; D005910:Glioma / Q000097:blood / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D006801:Humans; D008875:Middle Aged; D060787:Neoplasm Grading; D010641:Phenotype; D011944:Receptors, Androgen / Q000235:genetics; D012737:Sex Factors; D049951:X Chromosome Inactivation; D055815:Young Adult
chemical_list: C410798:AR protein, human; D014408:Biomarkers, Tumor; D011944:Receptors, Androgen